相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Dabrafenib plus trametinib in patients with BRAF V600E-mutant anaplastic thyroid cancer: updated analysis from the phase II ROAR basket study
V Subbiah et al.
ANNALS OF ONCOLOGY (2022)
International Medullary Thyroid Carcinoma Grading System: A Validated Grading System for Medullary Thyroid Carcinoma
Bin Xu et al.
JOURNAL OF CLINICAL ONCOLOGY (2022)
Copy number variations identified in thyroid FNA specimens are associated with Hurthle cell cytomorphology
Rita Abi-Raad et al.
CANCER CYTOPATHOLOGY (2022)
Overview of the 2022 WHO Classification of Neuroendocrine Neoplasms
Guido Rindi et al.
ENDOCRINE PATHOLOGY (2022)
Molecular classification of follicular thyroid carcinoma based on TERT promoter mutations
Hyunju Park et al.
MODERN PATHOLOGY (2022)
Genomic classification of benign adrenocortical lesions
Simon Faillot et al.
ENDOCRINE-RELATED CANCER (2021)
B7 immune-checkpoints as targets for the treatment of neuroendocrine tumors
Ziqiang Yuan et al.
ENDOCRINE-RELATED CANCER (2021)
Prevalence and Spectrum of DICER1 Mutations in Adult-onset Thyroid Nodules with Indeterminate Cytology
Anne-Sophie Chong et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2021)
Molecular Pathology of Poorly Differentiated and Anaplastic Thyroid Cancer: What Do Pathologists Need to Know
Marco Volante et al.
ENDOCRINE PATHOLOGY (2021)
What Did We Learn from the Molecular Biology of Adrenal Cortical Neoplasia? From Histopathology to Translational Genomics
C. Christofer Juhlin et al.
ENDOCRINE PATHOLOGY (2021)
DICER1 tumor predisposition syndrome: an evolving story initiated with the pleuropulmonary blastoma
Ivan A. Gonzalez et al.
MODERN PATHOLOGY (2021)
Analyzing Genetic Differences Between Sporadic Primary and Secondary/Tertiary Hyperparathyroidism by Targeted Next-Generation Panel Sequencing
Yu Ah Hong et al.
ENDOCRINE PATHOLOGY (2021)
Recurrent DICER1 Hotspot Mutations in Malignant Thyroid Gland Teratomas Molecular Characterization and Proposal for a Separate Classification
Lisa M. Rooper et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2020)
Pangenomic Classification of Pituitary Neuroendocrine Tumors
Mario Neou et al.
CANCER CELL (2020)
Frequency and Incidence of Carney Complex Manifestations: A Prospective Multicenter Study With a Three-Year Follow-Up
Stephanie Espiard et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2020)
Poorly differentiated thyroid carcinoma of childhood and adolescence: a distinct entity characterized by DICER1 mutations
Rebecca D. Chernock et al.
MODERN PATHOLOGY (2020)
Adrenocortical tumorigenesis: Lessons from genetics
Crystal D. C. Kamilaris et al.
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM (2020)
Clinicopathologic features of kinase fusion-related thyroid carcinomas: an integrative analysis with molecular characterization
Ying-Hsia Chu et al.
MODERN PATHOLOGY (2020)
Pheochromocytomas and paragangliomas in children: Data from the Italian Cooperative Study (TREP)
Calogero Virgone et al.
PEDIATRIC BLOOD & CANCER (2020)
RET,NTRK,ALK,BRAF, andMETFusions in a Large Cohort of Pediatric Papillary Thyroid Carcinomas
Barbora Pekova et al.
THYROID (2020)
Malignant teratoid tumor of the thyroid gland: an aggressive primitive multiphenotypic malignancy showing organotypical elements and frequent DICER1 alterations-is the term thyroblastoma more appropriate?
Abbas Agaimy et al.
VIRCHOWS ARCHIV (2020)
Parafibromin-deficient (HPT-JT Type, CDC73 Mutated) Parathyroid Tumors Demonstrate Distinctive Morphologic Features
Anthony J. Gill et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2019)
Molecular genetic insights into sporadic primary hyperparathyroidism
Kelly Brewer et al.
ENDOCRINE-RELATED CANCER (2019)
Ten years of DICER1 mutations: Provenance, distribution, and associated phenotypes
Leanne de Kock et al.
HUMAN MUTATION (2019)
Comprehensive characterization of a Canadian cohort of von Hippel-Lindau disease patients
Yasser Salama et al.
CLINICAL GENETICS (2019)
The Role of Immunohistochemistry and Molecular Analysis of Succinate Dehydrogenase in the Diagnosis of Endocrine and Non-Endocrine Tumors and Related Syndromes
Lindsey Oudijk et al.
ENDOCRINE PATHOLOGY (2019)
Genomic Profiling of Parathyroid Carcinoma Reveals Genomic Alterations Suggesting Benefit from Therapy
Hyunseok Kang et al.
ONCOLOGIST (2019)
GLIS Rearrangement is a Genomic Hallmark of Hyalinizing Trabecular Tumor of the Thyroid Gland
Marina N. Nikiforova et al.
THYROID (2019)
Genetic Analysis of 779 Advanced Differentiated and Anaplastic Thyroid Cancers
Nikita Pozdeyev et al.
CLINICAL CANCER RESEARCH (2018)
Cribriform-morular variant of thyroid carcinoma: a neoplasm with distinctive phenotype associated with the activation of the WNT/β-catenin pathway
Jose Manuel Cameselle-Teijeiro et al.
MODERN PATHOLOGY (2018)
Molecular Profile of Advanced Thyroid Carcinomas by Next-Generation Sequencing: Characterizing Tumors Beyond Diagnosis for Targeted Therapy
Hui Chen et al.
MOLECULAR CANCER THERAPEUTICS (2018)
Widespread Chromosomal Losses and Mitochondrial DNA Alterations as Genetic Drivers in Hurthle Cell Carcinoma
Raj K. Gopa et al.
CANCER CELL (2018)
European Society of Endocrinology Clinical Practice Guidelines on the management of adrenocortical carcinoma in adults, in collaboration with the European Network for the Study of Adrenal Tumors
Martin Fassnacht et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2018)
A common classification framework for neuroendocrine neoplasms: an International Agency for Research on Cancer (IARC) and World Health Organization (WHO) expert consensus proposal
Guido Rindi et al.
MODERN PATHOLOGY (2018)
Identification of recurrent USP48 and BRAF mutations in Cushing's disease
Jianhua Chen et al.
NATURE COMMUNICATIONS (2018)
Not the same thing: metastatic PTCs have a different background than ATCs
Dario de Biase et al.
ENDOCRINE CONNECTIONS (2018)
MEN4 and CDKN1B mutations: the latest of the MEN syndromes
Rami Alrezk et al.
ENDOCRINE-RELATED CANCER (2017)
Genomic profiling reveals mutational landscape in parathyroid carcinomas
Chetanya Pandya et al.
JCI INSIGHT (2017)
The USP8 mutational status may predict drug susceptibility in corticotroph adenomas of Cushing's disease
Kyohei Hayashi et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2016)
5th International ACC Symposium: Classification of Adrenocortical Cancers from Pathology to Integrated Genomics: Real Advances or Lost in Translation?
Ronald E. de Krijger et al.
HORMONES & CANCER (2016)
NTRK fusion oncogenes in pediatric papillary thyroid carcinoma in northeast United States
Manju L. Prasad et al.
CANCER (2016)
Recurrent EZH1 mutations are a second hit in autonomous thyroid adenomas
Davide Calebiro et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
Genomic and transcriptomic hallmarks of poorly differentiated and anaplastic thyroid cancers
Inigo Lancia et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
Mammary analog secretory carcinoma of the thyroid gland: A primary thyroid adenocarcinoma harboring ETV6-NTRK3 fusion
Snjezana Dogan et al.
MODERN PATHOLOGY (2016)
A Detailed Clinicopathologic Study of ALK-translocated Papillary Thyroid Carcinoma
Angela Chou et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2015)
A mutation screening of oncogenes, tumor suppressor gene TP53 and nuclear encoded mitochondrial complex I genes in oncocytic thyroid tumors
Cecilia Evangelisti et al.
BMC CANCER (2015)
ARMC5 Mutations in a Large Cohort of Primary Macronodular Adrenal Hyperplasia: Clinical and Functional Consequences
Stephanie Espiard et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2015)
Remarkable Response to Crizotinib in Woman With Anaplastic Lymphoma Kinase-Rearranged Anaplastic Thyroid Carcinoma
Yann Godbert et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Integrated Genomic Characterization of Papillary Thyroid Carcinoma
Nishant Agrawal et al.
CELL (2014)
Genomic Approaches to Problems in Pituitary Neoplasia
Sylvia L. Asa et al.
ENDOCRINE PATHOLOGY (2014)
Non-pheochromocytoma (PCC)/paraganglioma (PGL) tumors in patients with succinate dehydrogenase-related PCC-PGL syndromes: a clinicopathological and molecular analysis
Thomas G. Papathomas et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2014)
CDC73 Intragenic Deletion in Familial Primary Hyperparathyroidism Associated With Parathyroid Carcinoma
Eeva Korpi-Hyovalti et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2014)
Integrated genomic characterization of adrenocortical carcinoma
Guillaume Assie et al.
NATURE GENETICS (2014)
Identification of the transforming STRN-ALK fusion as a potential therapeutic target in the aggressive forms of thyroid cancer
Lindsey M. Kelly et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Frequent Large Germline HRPT2 Deletions in a French National Cohort of Patients With Primary Hyperparathyroidism
Leopoldine Bricaire et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2013)
Adrenocortical Carcinoma Is a Lynch Syndrome-Associated Cancer
Victoria M. Raymond et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Evidence of a Low Prevalence of RAS Mutations in a Large Medullary Thyroid Cancer Series
Raffaele Ciampi et al.
THYROID (2013)
MAX Mutations Cause Hereditary and Sporadic Pheochromocytoma and Paraganglioma
Nelly Burnichon et al.
CLINICAL CANCER RESEARCH (2012)
Parathyroid tumors and related disorders
Ronald A. DeLellis
MODERN PATHOLOGY (2011)
Molecular Classification and Prognostication of Adrenocortical Tumors by Transcriptome Profiling
Thomas J. Giordano et al.
CLINICAL CANCER RESEARCH (2009)
Clinical, genetic, and histopathologic investigation of CDC73-related familial hyperparathyroidism
Giulia Masi et al.
ENDOCRINE-RELATED CANCER (2008)
Familial hyperparathyroidism:: surgical outcome after 30 years of follow-up in three families with germline HRPT2 mutations
Marta S. Sarquis et al.
SURGERY (2008)
Identification of MEN1 and HRPT2 somatic mutations in paraffin-embedded (sporadic) parathyroid carcinomas
C. J. Haven et al.
CLINICAL ENDOCRINOLOGY (2007)
Parafibromin immunoreactivity:: its use as an additional diagnostic marker for parathyroid tumor classification
C. C. Juhlin et al.
ENDOCRINE-RELATED CANCER (2007)
Should parafibromin staining replace HRTP2 gene analysis as an additional tool for histologic diagnosis of parathyroid carcinoma?
Filomena Cetani et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2007)
IGFII and MIB1 immunohistochemistry is helpful for the differentiation of benign from malignant adrenocortical tumours
A. Schmitt et al.
HISTOPATHOLOGY (2006)
Hereditary leiomyomatosis associated with bilateral, massive, macronodular adrenocortical disease and atypical Cushing syndrome: A clinical and molecular genetic investigation
L Matyakhina et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2005)
Clinical characteristics of pheochromocytoma patients with germline mutations in SDHD
H Dannenberg et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Differential expression of the calcium sensing receptor and combined loss of chromosomes 1q and 11q in parathyroid carcinoma
CJ Haven et al.
JOURNAL OF PATHOLOGY (2004)
PAX8-PPARγ1 fusion in oncogene human thyroid carcinoma
TG Kroll et al.
SCIENCE (2000)
分享论文
